Tempus AI, Inc. logo
Nasdaq: TEM · expanding
Data & tooling
PROBABLE

Tempus AI, Inc.

A healthcare data and technology company applying AI to precision medicine and patient care.

Data & toolingAI productsHealthcare & drug discoveryOfficial website

Research candidate, not an investment rating. Identity and classification reflect a bounded evidence snapshot observed Jul 26, 2026.

VCAI-RC-0012-EXP-01
External market projection

TEM market context

Close Aug 4, 2026 · Yahoo Finance chart endpoint
$47.05
Latest close
+2.17%
1 day
-21.93%
30 days
-18.51%
1 year
$104.32
52w high
$40.77
52w low
External end-of-day market projection. It is not canonical company knowledge and may be delayed or corrected by the provider.Source projection
Regulator-sourced financials

SEC financial snapshot

CIK 0001717115 · Services-Computer Programming, Data Processing, Etc.
Latest quarter · 10-Q

Period ended Jun 30, 2026 · filed Jul 30, 2026

Open filing
$382.5M
Revenue
Unknown
Gross profit
$-75.9M
Operating income
$5.6M
Net income
Latest annual · 10-K

Period ended Dec 31, 2025 · filed Feb 24, 2026

Open filing
$1.3B
Revenue
Unknown
Gross profit
$-252.9M
Operating income
$-245M
Net income

Values are issuer-filed XBRL facts retrieved from SEC EDGAR. Missing concepts remain Unknown; non-GAAP values are not substituted.

Explainable company intelligence

What makes this an AI company—and what changed recently.

AI roles are presented as source-anchored research interpretations. The document stream is regulator-primary, but a filing’s existence does not prove the claims contained inside it.

AI Exposure Ledger

Role evidence, not a proprietary investment score

2 dimensions

Data & tooling

Primary classified role
REAL-009-EXP-01

The issuer supplies data, evaluation or engineering capabilities used in AI development.

Evidence basis

The annual filing identifies Tempus AI, its TEM listing and its technology and data business in precision medicine.

Anchors: SRC-REAL-009-A · SRC-REAL-009-B

AI products

Material supporting role
REAL-009-EXP-02

AI is a material capability inside one or more current products or services.

Evidence basis

Issuer results report current revenue and an operating technology business applying AI to healthcare.

Anchors: SRC-REAL-009-A · SRC-REAL-009-B

Why it is in the map

01

The annual filing identifies Tempus AI, its TEM listing and its technology and data business in precision medicine.

02

Issuer results report current revenue and an operating technology business applying AI to healthcare.

Evidence chain

These sources support the issuer/listing and AI-exposure assessment. First-party evidence proves attribution—not independent truth.

Official filing or report · E3
Tempus AI 2025 Form 10-K
SRC-REAL-009-A
Official filing or report · E3
Tempus Full Year 2025 Results
SRC-REAL-009-B

What would trigger a review

  • New annual report or material acquisition integration.
  • Regulatory or product-status change affecting named AI offerings.
  • Listing, symbol or issuer change.